期刊文献+

静脉输液合理用药监控平台的建立和应用 被引量:12

Establishment and application of monitoring platform for rational use of intravenous infusion
原文传递
导出
摘要 目的:通过建立静脉输液合理用药监控平台,实时监控审方过程中的不合理医嘱,同时注重成品输液的稳定性和滴注速度的控制,最大程度上促进患者合理用药,减少不良反应。方法:监控平台会自动将滴注速度单位统一为mL·min-1,根据成品输液稳定性不同,进行先后顺序自动排序。成品输液放置时间系统和滴速控制和监控系统可监控临床输液的使用情况。结果:成品输液出舱到病区时间平均减少15~20 min;稳定时间2 h、4 h和6 h内的成品输液执行及时率得到显著提高;输液滴注速度合理率由运行前的58.5%上升至88.8%;单季度输液不良反应量降幅高达45.7%。结论:通过建立完善的、全面的静脉输液合理用药监控平台,实现某院PIVAS静脉输液全流程的闭环监控,为我国医院PIVAS合理用药监控平台的补充和完善提供参考。 OBJECTIVE To establish a monitoring platform for rational use of intravenous infusion, which can not only monitor unreasonable orders in the process of prescription review in real time, but also pay more attention to the stability of finished infusion and the control of infusion speed, so as to maximize the rational medication and reduce adverse reactions.METHODS The monitoring platform automatically unify the infusion speed unit as mL·min-1, and automatically arrange the order of preparation according to the stability of finished infusion. The application of clinical infusion can be monitored by the finished infusion placement time system and infusion rate control and monitoring system.RESULTS The average time of finished product infusion from the cabin to the ward was reduced by 15-20 minutes;the timely rate of finished product infusion within 2, 4 and 6 hours of stable time was significantly improved;the reasonable rate of infusion speed increased from 58.5% to 88.8% before operation;the decrease in the amount of adverse reactions of the infusion in a single quarter was as high as 45.7%.CONCLUSION By establishing a perfect and comprehensive monitoring platform for rational drug use of intravenous infusion, the closed-loop monitoring of the whole process of intravenous infusion of PIVAS in a hospital is realized, which provides a reference for the supplement and improvement of the monitoring platform for rational drug use of PIVAS in hospitals in China.
作者 刘馨 李然 薛苏冬 沈云士 蒋凯 周琴 LIU Xin;LI Ran;XUE Su-dong;SHEN Yun-shi;JIANG Kai;ZHOU Qin(Department of Pharmacy,Nanjing-Medical University Affiliated Suzhou Hospital,Jiangsu Suzhou 215002.China)
出处 《中国医院药学杂志》 CAS 北大核心 2020年第23期2479-2483,共5页 Chinese Journal of Hospital Pharmacy
基金 苏州市科技发展项目(编号:SYSD2018242,SS201848)。
关键词 静脉输液 放置时间 滴注速度 合理用药 监控 intravenous infusion placement time infusion rate rational medication monitoring
  • 相关文献

参考文献9

二级参考文献90

  • 1陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 2中华人民共和国卫生部,国家食品药品监督管理局,国家中医药管理局.中药注射剂临床使用基本原则[J].药物不良反应杂志,2009,11(1):43-44.
  • 3李大魁,金有豫,汤光.马丁代尔药物大典[M].北京:化学工业出版社,2009: 1799.
  • 4国家食品药品监督管理局.《药物临床试验质量管理规范》(局令第3号)[EB/OL].http://www.sda.gov.cn/wsol/cL0053/24473.html,2003-8-6.
  • 5国家食品药品监督管理局.《药品注册管理办法》(局令第28号)[EB/OL].(2007-07-10)[2014-07-15].http://www.sda.gov.cn,WS01/CL0053/24529.html.
  • 6国家食品药品监督管理局.《药品管理法》(释义)[EB/OL].http://www.szfda.gov.cn/WS01/CL0603/23409 html,(2002-1-20).
  • 7广东省卫生和计划生育委员会.广东省医疗机构阳光用药制度建设验收工作标准[S].2012-11-23.
  • 8卫生部医疗服务监管司.三级综合医院评审标准实施细则[S].2011-11-25.
  • 9庞晓军,王小平,车红英,黄永婵.干预策略对临床细菌耐药率的影响[J].中国医院药学杂志,2008,28(2):135-137. 被引量:6
  • 10毛国富.氟罗沙星注射液在常用输液中的稳定性探讨[J].齐齐哈尔医学院学报,2008,29(2):148-149. 被引量:6

共引文献227

同被引文献156

引证文献12

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部